000169294 001__ 169294
000169294 005__ 20240229133648.0
000169294 0247_ $$2doi$$a10.1007/s10654-021-00772-2
000169294 0247_ $$2pmid$$apmid:34148186
000169294 0247_ $$2ISSN$$a0393-2990
000169294 0247_ $$2ISSN$$a1573-7284
000169294 0247_ $$2altmetric$$aaltmetric:107949326
000169294 037__ $$aDKFZ-2021-01391
000169294 041__ $$aEnglish
000169294 082__ $$a610
000169294 1001_ $$aCastro-Espin, Carlota$$b0
000169294 245__ $$aInflammatory potential of the diet and risk of breast cancer in the European Investigation into Cancer and Nutrition (EPIC) study.
000169294 260__ $$aDordrecht [u.a.]$$bSpringer Science + Business Media B.V.$$c2021
000169294 3367_ $$2DRIVER$$aarticle
000169294 3367_ $$2DataCite$$aOutput Types/Journal article
000169294 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1634825327_21237
000169294 3367_ $$2BibTeX$$aARTICLE
000169294 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000169294 3367_ $$00$$2EndNote$$aJournal Article
000169294 500__ $$a 2021 Sep;36(9):953-964
000169294 520__ $$aThe role of chronic inflammation on breast cancer (BC) risk remains unclear beyond as an underlying mechanism of obesity and physical activity. We aimed to evaluate the association between the inflammatory potential of the diet and risk of BC overall, according to menopausal status and tumour subtypes. Within the European Prospective Investigation into Cancer and Nutrition cohort, 318,686 women were followed for 14 years, among whom 13,246 incident BC cases were identified. The inflammatory potential of the diet was characterized by an inflammatory score of the diet (ISD). Multivariable Cox regression models were used to assess the potential effect of the ISD on BC risk by means of hazard ratios (HR) and 95% confidence intervals (CI). ISD was positively associated with BC risk. Each increase of one standard deviation (1-Sd) of the score increased by 4% the risk of BC (HR = 1.04; 95% CI 1.01-1.07). Women in the highest quintile of the ISD (indicating a most pro-inflammatory diet) had a 12% increase in risk compared with those in the lowest quintile (HR = 1.12; 95% CI 1.04-1.21) with a significant trend. The association was strongest among premenopausal women, with an 8% increased risk for 1-Sd increase in the score (HR = 1.08; 95% CI 1.01-1.14). The pattern of the association was quite homogeneous by BC subtypes based on hormone receptor status. There were no significant interactions between ISD and body mass index, physical activity, or alcohol consumption. Women consuming more pro-inflammatory diets as measured by ISD are at increased risk for BC, especially premenopausal women.
000169294 536__ $$0G:(DE-HGF)POF4-313$$a313 - Krebsrisikofaktoren und Prävention (POF4-313)$$cPOF4-313$$fPOF IV$$x0
000169294 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo01.inet.dkfz-heidelberg.de
000169294 650_7 $$2Other$$aBreast cancer
000169294 650_7 $$2Other$$aChronic inflammation
000169294 650_7 $$2Other$$aInflammatory potential of the diet
000169294 650_7 $$2Other$$aProspective study
000169294 7001_ $$aAgudo, Antonio$$b1
000169294 7001_ $$aBonet, Catalina$$b2
000169294 7001_ $$0P:(DE-He78)fb68a9386399d72d84f7f34cfc6048b4$$aKatzke, Verena$$b3$$udkfz
000169294 7001_ $$0P:(DE-He78)74a6af8347ec5cbd4b77e562e10ca1f2$$aTurzanski-Fortner, Renée$$b4$$udkfz
000169294 7001_ $$aAleksandrova, Krasimira$$b5
000169294 7001_ $$aSchulze, Matthias B$$b6
000169294 7001_ $$aTjønneland, Anne$$b7
000169294 7001_ $$aDahm, Christina C$$b8
000169294 7001_ $$aQuirós, José-Ramón$$b9
000169294 7001_ $$aSánchez, María-José$$b10
000169294 7001_ $$aAmiano, Pilar$$b11
000169294 7001_ $$aChirlaque, María-Dolores$$b12
000169294 7001_ $$aArdanaz, Eva$$b13
000169294 7001_ $$aMasala, Giovanna$$b14
000169294 7001_ $$aSieri, Sabina$$b15
000169294 7001_ $$aTumino, Rosario$$b16
000169294 7001_ $$aSacerdote, Carlotta$$b17
000169294 7001_ $$aPanico, Salvatore$$b18
000169294 7001_ $$aMay, Anne M$$b19
000169294 7001_ $$aBodén, Stina$$b20
000169294 7001_ $$aGram, Inger T$$b21
000169294 7001_ $$aSkeie, Guri$$b22
000169294 7001_ $$aLaouali, Nasser$$b23
000169294 7001_ $$aShah, Sanam$$b24
000169294 7001_ $$aSeveri, Gianluca$$b25
000169294 7001_ $$aAune, Dagfinn$$b26
000169294 7001_ $$aMerritt, Melissa A$$b27
000169294 7001_ $$aCairat, Manon$$b28
000169294 7001_ $$aWeiderpass, Elisabete$$b29
000169294 7001_ $$aRiboli, Elio$$b30
000169294 7001_ $$aDossus, Laure$$b31
000169294 7001_ $$aJakszyn, Paula$$b32
000169294 773__ $$0PERI:(DE-600)2004992-4$$a10.1007/s10654-021-00772-2$$n9$$p953-964$$tEuropean journal of epidemiology$$v36$$x1573-7284$$y2021
000169294 909CO $$ooai:inrepo02.dkfz.de:169294$$pVDB
000169294 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)fb68a9386399d72d84f7f34cfc6048b4$$aDeutsches Krebsforschungszentrum$$b3$$kDKFZ
000169294 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)74a6af8347ec5cbd4b77e562e10ca1f2$$aDeutsches Krebsforschungszentrum$$b4$$kDKFZ
000169294 9131_ $$0G:(DE-HGF)POF4-313$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vKrebsrisikofaktoren und Prävention$$x0
000169294 9130_ $$0G:(DE-HGF)POF3-313$$1G:(DE-HGF)POF3-310$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vCancer risk factors and prevention$$x0
000169294 9141_ $$y2021
000169294 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz$$d2021-01-28$$wger
000169294 915__ $$0StatID:(DE-HGF)0430$$2StatID$$aNational-Konsortium$$d2021-01-28$$wger
000169294 915__ $$0StatID:(DE-HGF)3002$$2StatID$$aDEAL Springer$$d2021-01-28$$wger
000169294 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2021-01-28
000169294 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2021-01-28
000169294 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2021-01-28
000169294 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences$$d2021-01-28
000169294 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2021-01-28
000169294 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2021-01-28
000169294 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2021-01-28
000169294 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2021-01-28
000169294 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2021-01-28
000169294 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2021-01-28
000169294 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bEUR J EPIDEMIOL : 2019$$d2021-01-28
000169294 915__ $$0StatID:(DE-HGF)9905$$2StatID$$aIF >= 5$$bEUR J EPIDEMIOL : 2019$$d2021-01-28
000169294 9201_ $$0I:(DE-He78)C020-20160331$$kC020$$lC020 Epidemiologie von Krebs$$x0
000169294 980__ $$ajournal
000169294 980__ $$aVDB
000169294 980__ $$aI:(DE-He78)C020-20160331
000169294 980__ $$aUNRESTRICTED